LL-37

Quick Start Highlight

LL‑37 is a cationic antimicrobial peptide (AMP) and the only member of the human cathelicidin family. It’s derived from a larger precursor protein called hCAP18, and it plays a pivotal role in innate immune defense by fighting off bacterial, viral, and fungal infections.

LL‑37 is produced naturally by immune cells, epithelial cells, and bone marrow-derived cells in response to infection or tissue injury. It acts as both an antimicrobial agent and a signaling molecule that regulates inflammation, tissue repair, and immune response.

Key Characteristics of LL‑37:

• Broad-spectrum antimicrobial action (kills bacteria, viruses, fungi)

• Promotes wound healing and epithelial cell migration

• Regulates inflammatory responses by modulating cytokines

• Supports tissue regeneration and immune system priming

• Found naturally in skin, lungs, gastrointestinal tract, and bone marrow

Unlike other therapeutic peptides, LL‑37 doesn’t target muscle growth or hormonal function. Instead, it enhances recovery and resilience by modulating the body’s immune and healing mechanisms—making it particularly useful in infection-prone or inflammation-heavy conditions.

Benefits of LL-37

Unlike performance peptides that focus on muscle growth or hormonal balance, LL‑37 shines in areas of immune function, infection control, and tissue recovery. Its versatility makes it appealing for athletes, biohackers, and individuals with chronic inflammation or persistent injuries.

Antibacterial, Antiviral, and Antifungal Defense

LL‑37 has potent broad-spectrum antimicrobial effects. It can neutralize a wide range of pathogens, including gram-positive and gram-negative bacteria, fungi, and enveloped viruses like influenza and herpes.

• Active against Staphylococcus aureus, E. coli, Pseudomonas, Candida, and MRSA

• Useful in skin infections, wound healing, and respiratory tract infections

• May reduce frequency and severity of cold and flu-like illnesses

Wound Healing and Skin Regeneration

LL‑37 promotes rapid healing of cuts, abrasions, ulcers, and burns by stimulating cell migration, collagen synthesis, and angiogenesis.

• Useful for acne scars, diabetic ulcers, or post-surgical wounds

• May support dermatological recovery from eczema or psoriasis

• Enhances fibroblast function and tissue strength in healing phases

Gut Health and Inflammation Control

LL‑37 is expressed in the gastrointestinal tract, where it defends against pathogenic bacteria and supports epithelial integrity. It may help in conditions like leaky gut, IBD, or chronic bloating.

• Reduces intestinal inflammation

• Supports gut lining repair and mucosal immune defense

• Often stacked with BPC‑157 for synergistic GI recovery

Immune Priming and Anti-Inflammatory Effects

LL‑37 plays a dual role in stimulating the immune system and reducing unnecessary inflammation, depending on what's needed. It may enhance overall immune readiness, especially during periods of stress, travel, or illness.

• Balances immune responses without overstimulation

• May reduce chronic inflammation in autoimmune conditions

• Supports recovery from upper respiratory and GI infections

How Does LL-37 Work?

LL‑37 exerts its effects through multiple physiological pathways, targeting both pathogen elimination and tissue regeneration. Its actions are localized and systemic, meaning it can be effective whether used for skin wounds, gut health, or internal immune support.

Direct Antimicrobial Action

LL‑37 disrupts the cell membranes of bacteria, viruses, and fungi, leading to microbial death. Unlike traditional antibiotics, LL‑37 is less prone to resistance due to its broad, non-specific mechanism.

• Inserts into microbial membranes and forms pores

• Causes lysis of bacterial or fungal cells

• Effective against antibiotic-resistant strains like MRSA

 Immune System Modulation

LL‑37 helps regulate the inflammatory cascade, acting as a chemoattractant for immune cells (like neutrophils and macrophages) and modulating cytokine release. It can either promote or suppress inflammation depending on the local environment.

• Stimulates immune cells at injury or infection sites

• Reduces pro-inflammatory cytokines (e.g., TNF‑α, IL‑6) in chronic inflammation

• Enhances production of anti-inflammatory mediators

Wound Healing and Tissue Repair

• LL‑37 supports epithelial cell proliferation, angiogenesis (new blood vessel formation), and extracellular matrix remodeling, accelerating the healing of skin, mucosal surfaces, and even GI tissues.

• Promotes keratinocyte and fibroblast migration

• Enhances collagen deposition and tissue strength

• Speeds recovery in skin wounds, ulcers, and gut lining damage

Potential Side Effects

Gut Disruption at High Doses

• Overstimulation in Autoimmune Conditions

• Flu-like Symptoms or Systemic Inflammation

• Injection site irritation (swelling, redness, or discomfort)

Dosing & Reconstitution Guide

Educational guide for reconstitution and weekly dosing